Skip to main content
Development Programs

Advancing Novel Treatments for Patients with Muscle Disease

Kate Therapeutics has established a pipeline of genetic muscle and cardiac disease indications that can be uniquely addressed by our proprietary capsid and cargo technologies.

  Discovery

     Lead Candidate

 Nonclinical Development

Clinical Development

X-Linked Myotubular Myopathy

Asetllas Logo

Nonclinical Development

65%

Facioscapulohumeral Dystrophy

Lead Candidate

40%

Muscular Dystrophy

Lead Candidate

40%

Muscular Dystrophy

Lead Candidate

40%

Cardiomyopathy

Discovery

15%

Myotonic Dystrophy Type 1

Discovery

15%

New Hope for Patients with Muscle and Heart Disease

Kate Therapeutics is a privately-held company with experienced leadership, a world-class scientific advisory team, and leading investor partners.

Contact Us

Kate Therapeutics, Inc.
10675 Sorrento Valley Road, Suite 150
San Diego, CA 92121

Contact Form

Explore Careers

Join us in our mission to advance the next generation of gene therapies. Learn more »

News Alerts
LinkedIn
Terms of Use
Privacy Policy
Accessibility